This guidance sets out the circumstances in which it may be appropriate to offer a course of prophylactic antiviral medicine to patients with a serious underlying medical condition or who are pregnant during the H1N1 (swine flu) pandemic.
Related articles
-
HSJ KnowledgePartnership working and the flu pandemic
The H1N1 pandemic never reached the intensity feared, but the emergency response set in place has strengthened partnership working.
-
NewsSwine flu vaccine bill cost department £239m
The government spent £239m on the swine flu vaccine, official figures reveal.
-
NewsRise in intensive care beds occupied by flu patients
The number of flu cases being treated in critical care beds has increased by 66 per cent in the last week, according to figures released by the Department of Health.
More from News
-
NewsThe 50 most influential people for NHS tech in 2026: The full list
Top 10 1. Lawrence Tallon, CEO, Medicines and Healthcare products Regulatory Agency Mr Tallon is leading the MHRA into a new and challenging era. The regulator had fallen behind on overseeing artificial intelligence and other technology, and the former Guy’s and St Thomas’ Foundation Trust deputy chief ...
-
HSJ AwardsHSJ Digital Awards 2026: Reducing Health Inequalities through Digital
WINNER NHS England NHS England Centralised Maternity Self-Referral
-
HSJ AwardsHSJ Digital Awards 2026: Outstanding Achievement in EPR Implementation and Optimisation
WINNER University Hospitals of Derby and Burton (UHDB) and Chesterfield Royal Hospital (CRH) Thousands of patients are benefiting from new, joint electronic patient record across six hospitals through quality and safety improvements and millions of hours released back to care
No comments yet